# Characterizing Transcranial Focused Ultrasound Neuromodulation During Sedation

> **NCT07161518** · PHASE4 · ENROLLING_BY_INVITATION · sponsor: **Stanford University** · enrollment: 10 (estimated)

## Conditions studied

- Healthy Participants

## Interventions

- **DEVICE:** Low-intensity transcranial ultrasound
- **DEVICE:** Low-intensity transcranial ultrasound
- **DRUG:** Propofol

## Key facts

- **NCT ID:** NCT07161518
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2025-09-01
- **Primary completion:** 2027-08
- **Final completion:** 2027-08
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2026-03-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07161518

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07161518, "Characterizing Transcranial Focused Ultrasound Neuromodulation During Sedation". Retrieved via AI Analytics 2026-06-13 from https://api.ai-analytics.org/clinical/NCT07161518. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*